{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:32:00Z","timestamp":1790065920492,"version":"4.0.1"},"reference-count":207,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jaad.2023.10.071","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T11:44:55Z","timestamp":1706269495000},"page":"651-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Safety of dermatologic medications in pregnancy and lactation: An update\u2014Part II: Lactation"],"prefix":"10.1016","volume":"91","author":[{"given":"Marita","family":"Yaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"McMullan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu M.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marti","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Murase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Grant-Kels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2023.10.071_bib1","series-title":"Hale & Hartmann\u2019s Textbook of Human Lactation","author":"Hale","year":"2017"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/dth.12071","article-title":"Dermatoses of the breast in lactation","volume":"26","author":"Barrett","year":"2013","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib3","first-page":"185","article-title":"Factitious hypertension with mineralocorticoid excess in an infant","volume":"38","author":"De Stefano","year":"1983","journal-title":"Helv Paediatr Acta"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2133.2008.08974.x","article-title":"Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis","volume":"160","author":"Undre","year":"2009","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/09546630510033159","article-title":"A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis","volume":"16","author":"Ling","year":"2005","journal-title":"J Dermatol Treat"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib6","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1097\/TP.0b013e3182654d36","article-title":"Follow-up of tacrolimus breastfed babies","volume":"94","author":"Gouraud","year":"2012","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2215\/CJN.06400612","article-title":"Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants","volume":"8","author":"Bramham","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/01.AOG.0000164052.66219.c7","article-title":"Breastfeeding during tacrolimus therapy","volume":"107","author":"Gardiner","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2023.10.071_bib9","first-page":"65","article-title":"Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation","author":"Coscia","year":"2010","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jaad.2023.10.071_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/AOG.0b013e31825f01f8","article-title":"Pregnancy in an intestinal transplant recipient","volume":"120","author":"Gomez-Lobo","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1525-1470.2009.00880.x","article-title":"Uptake of pyrene in a breast-fed child of a mother treated with coal tar","volume":"26","author":"Scheepers","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2023.10.071_bib12","series-title":"Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk","author":"Briggs","year":"2008"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0022-3476(82)80689-6","article-title":"Maternal-infant vitamin D relationships during breast-feeding","volume":"101","author":"Rothberg","year":"1982","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ad.2020.10.002","article-title":"Management of psoriasis during preconception, pregnancy, postpartum, and breastfeeding: a consensus statement","volume":"112","author":"Belinch\u00f3n","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"issue":"11","key":"10.1016\/j.jaad.2023.10.071_bib15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/dsu.12322","article-title":"Safety of cosmetic dermatologic procedures during pregnancy","volume":"39","author":"Lee","year":"2013","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib16","first-page":"487","article-title":"Acitretin excretion into human breast milk","volume":"70","author":"Rollman","year":"1990","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2023.10.071_bib17","series-title":"Food and Drug Administration. Acitretin [Package Insert]","year":"2017"},{"key":"10.1016\/j.jaad.2023.10.071_bib18","series-title":"Drugs and Human Lactation: A Comprehensive Guide to the Content and Consequences of Drugs, Micronutrients, Radiopharmaceuticals, and Environmental and Occupational Chemicals in Human Milk","author":"Jensen","year":"1996"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"Transfer of drugs and other chemicals into human milk","volume":"108","year":"2001","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.jaad.2023.10.071_bib20","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0002-9378(72)90824-1","article-title":"Secretion of methotrexate into human milk","volume":"112","author":"Johns","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2023.10.071_bib21","series-title":"Methotrexate in Breast Milk","first-page":"711","author":"Delaney","year":"2017"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"10.1016\/j.jaad.2023.10.071_bib23","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1097\/01.TP.0000066352.86763.D0","article-title":"Cyclosporine excretion into breast milk","volume":"75","author":"Moretti","year":"2003","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7182\/pit2013803","article-title":"Safety considerations: breastfeeding after transplant","volume":"23","author":"Thiagarajan","year":"2013","journal-title":"Prog Transplant"},{"issue":"8","key":"10.1016\/j.jaad.2023.10.071_bib25","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bpobgyn.2014.09.001","article-title":"Breast-feeding after transplantation","volume":"28","author":"Constantinescu","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13006-022-00514-4","article-title":"Breastfeeding by a mother taking cyclosporine for nephrotic syndrome","volume":"17","author":"Li","year":"2022","journal-title":"Int Breastfeed J"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-4632.2012.05534.x","article-title":"Levels of cyclosporine in breast milk and passage into the circulation of the infant of a mother with psoriasis","volume":"53","author":"Mazzuoccolo","year":"2014","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199801270-00019","article-title":"Breast-feeding during treatment with cyclosporine1","volume":"65","author":"Nyberg","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2023.10.071_bib29","series-title":"Crisaborole [Package Insert]","year":"2020"},{"key":"10.1016\/j.jaad.2023.10.071_bib30","series-title":"Roflumilast [Package Insert]","year":"2015"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2008.03.018","article-title":"Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases","volume":"59","author":"Lam","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2023.10.071_bib32","series-title":"Tapiranof [Package Insert]","year":"2022"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40257-021-00641-4","article-title":"Tapinarof cream 1% for extensive plaque psoriasis: a maximal use trial on safety, tolerability, and pharmacokinetics","volume":"23","author":"Jett","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2023.10.071_bib34","series-title":"Upadacitinib [Package Insert]","year":"2023"},{"key":"10.1016\/j.jaad.2023.10.071_bib35","series-title":"Roxulitinib [Package Insert]","year":"2023"},{"key":"10.1016\/j.jaad.2023.10.071_bib36","series-title":"Xeljanz\/Xeljanz XR use in specific populations","year":"2021"},{"key":"10.1016\/j.jaad.2023.10.071_bib37","series-title":"Deucravacitinib [Package Insert]","year":"2022"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jbspin.2015.07.004","article-title":"Certolizumab treatment during late pregnancy in patients with rheumatic diseases: low drug levels in cord blood but possible risk for maternal infections. A case series of 13 patients","volume":"83","author":"F\u00f6rger","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cgh.2012.11.011","article-title":"Placental transfer of anti\u2013tumor necrosis factor agents in pregnant patients with inflammatory bowel disease","volume":"11","author":"Mahadevan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.jaad.2023.10.071_bib40","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1136\/annrheumdis-2017-211384","article-title":"Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study","volume":"76","author":"Clowse","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2018.05.040","article-title":"Exposure concentrations of infants breastfed by women receiving biologic therapies for inflammatory bowel diseases and effects of breastfeeding on infections and development","volume":"155","author":"Matro","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ibd\/izz037","article-title":"Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project Working Group","volume":"25","author":"Mahadevan","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.jaad.2023.10.071_bib43","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1136\/ard.2008.105924","article-title":"Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant\u2019s serum","volume":"68","author":"Murashima","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.jaad.2023.10.071_bib44","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/rheumatology\/keq185","article-title":"Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding","volume":"49","author":"Berthelsen","year":"2010","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.jaad.2023.10.071_bib45","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/MCG.0b013e31825f2807","article-title":"Infliximab and adalimumab use during breastfeeding","volume":"46","author":"Fritzsche","year":"2012","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"10.1016\/j.jaad.2023.10.071_bib46","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.crohns.2012.10.009","article-title":"Adalimumab levels in an infant","volume":"7","author":"Julsgaard","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"9","key":"10.1016\/j.jaad.2023.10.071_bib47","first-page":"753","article-title":"Infliximab in breast milk","volume":"13","author":"F\u00f6rger","year":"2004","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.crohns.2013.09.003","article-title":"Infliximab concentrations in the milk of nursing mothers with inflammatory bowel disease","volume":"8","author":"Grosen","year":"2014","journal-title":"J Crohns Colitis"},{"issue":"9","key":"10.1016\/j.jaad.2023.10.071_bib49","doi-asserted-by":"crossref","first-page":"e1156","DOI":"10.1111\/jdv.19165","article-title":"Dupilumab for atopic dermatitis during pregnancy and breastfeeding: clinical experience in 13 patients","volume":"37","author":"Escol\u00e0","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib50","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1111\/jdv.16235","article-title":"A case of atopic eczema treated safely with dupilumab during pregnancy and lactation","volume":"34","author":"Kage","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib51","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1474-4422(22)00426-4","article-title":"Family planning considerations in people with multiple sclerosis","volume":"22","author":"Krysko","year":"2023","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/ecco-jcc\/jjy153","article-title":"Drug levels in the maternal serum, cord blood and breast milk of a ustekinumab-treated patient with Crohn\u2019s disease","volume":"13","author":"Klenske","year":"2019","journal-title":"J Crohns Colitis"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib53","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ibd\/izaa325","article-title":"Detection of ustekinumab in breast milk of nursing mothers with Crohn disease","volume":"27","author":"Bar-Gil Shitrit","year":"2021","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40780-022-00249-8","article-title":"Ustekinumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk, and infant serum","volume":"8","author":"Saito","year":"2022","journal-title":"J Pharm Health Care Sci"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12895","article-title":"Biologics exposure during pregnancy and breastfeeding in a psoriasis patient","volume":"32","author":"Mugheddu","year":"2019","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib56","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/ecco-jcc\/jjad005","article-title":"Vaccines in children exposed to biological agents in utero and\/or during breastfeeding: are they effective and safe?","volume":"17","author":"Gisbert","year":"2023","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib57","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/ajd.12641","article-title":"Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration","volume":"59","author":"Rademaker","year":"2018","journal-title":"Australas J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib58","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bjd.19039","article-title":"British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update","volume":"183","author":"Smith","year":"2020","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0190-9622(08)81977-9","article-title":"Plasma levels of 8-methoxypsoralen after topical paint PUVA on nonpalmoplantar psoriatic skin","volume":"31","author":"Hallman","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib60","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2133.1982.tb00929.x","article-title":"Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen","volume":"106","author":"Neild","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2023.10.071_bib61","series-title":"Methoxsalen [Package Insert]","first-page":"8","year":"2018"},{"issue":"9","key":"10.1016\/j.jaad.2023.10.071_bib62","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jcph.1122","article-title":"Prednisone pharmacokinetics during pregnancy and lactation","volume":"58","author":"Ryu","year":"2018","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib63","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/WHE.10.24","article-title":"Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases","volume":"6","author":"Elliott","year":"2010","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.jaad.2023.10.071_bib64","series-title":"Prednisone. Drugs and Lactation Database (LactMed) [Internet]","year":"2006"},{"issue":"9","key":"10.1016\/j.jaad.2023.10.071_bib65","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/art.20648","article-title":"Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: comment on the article by Costedoat-Chalumeau et\u00a0al","volume":"50","author":"Cimaz","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib66","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2125.1984.tb02358.x","article-title":"Excretion of hydroxychloroquine in human milk","volume":"17","author":"Nation","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2023.10.071_bib67","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00228-019-02723-z","article-title":"Breast milk concentration of hydroxychloroquine in Chinese lactating women with connective tissue diseases","volume":"75","author":"Peng","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib68","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/cpt.1864","article-title":"Chloroquine dosing recommendations for pediatric COVID-19 supported by modeling and simulation","volume":"108","author":"Verscheijden","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib69","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1177\/0961203321995263","article-title":"Breastfeeding in women affected by systemic lupus erythematosus: rate, duration and associated factors","volume":"30","author":"Orefice","year":"2021","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib70","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/rheumatology\/keac372","article-title":"Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine","volume":"62","author":"Reynolds","year":"2023","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000491","article-title":"Breastfeeding in women with rheumatic diseases","volume":"8","author":"Ikram","year":"2021","journal-title":"Lupus Sci Med"},{"issue":"9305","key":"10.1016\/j.jaad.2023.10.071_bib72","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(02)07643-2","article-title":"Antimalarial agents in pregnancy","volume":"359","author":"Motta","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2023.10.071_bib73","series-title":"Breastfeeding and Maternal Medication: Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs","first-page":"43","year":"2003"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib74","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2125.1986.tb02967.x","article-title":"Excretion of chloroquine, dapsone and pyrimethamine in human milk","volume":"22","author":"Edstein","year":"1986","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib75","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7326\/0003-4819-96-4-465","article-title":"Hemolytic anemia induced by dapsone transmitted through breast milk","volume":"96","author":"Sanders","year":"1982","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib76","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.kint.2021.05.010","article-title":"Measurement of the passage of mycophenolic acid into breast milk in a patient with lupus nephritis","volume":"100","author":"Huerta","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaad.2023.10.071_bib77","series-title":"Mycophenolate Mofetil [Package Insert]","year":"2008"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib78","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.healun.2020.02.005","article-title":"Pregnancy outcomes in heart transplant recipients","volume":"39","author":"Punnoose","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089151","article-title":"Pregnancy outcomes in liver and cardiothoracic transplant recipients: a UK national cohort study","volume":"9","author":"Mohamed-Ahmed","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib80","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.hlc.2020.10.007","article-title":"Pregnancy following heart transplantation: a single centre case series and review of the literature","volume":"30","author":"Boyle","year":"2021","journal-title":"Heart Lung Circ"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib81","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.jaad.2023.10.071_bib82","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1345\/aph.1H152","article-title":"Breast-feeding during maternal use of azathioprine","volume":"40","author":"Moretti","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib83","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.crohns.2010.10.005","article-title":"Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding","volume":"5","author":"Angelberger","year":"2011","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib84","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1345\/aph.1H152a","article-title":"Comment: breast-feeding during maternal use of azathioprine","volume":"41","author":"Gardiner","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib85","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ecco-jcc\/jju006","article-title":"The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease","volume":"9","author":"Van der Woude","year":"2015","journal-title":"J Crohns Colitis"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib86","article-title":"Pemphigoid gestationis and adverse pregnancy outcomes: a literature review","volume":"51","author":"Abdelhafez","year":"2022","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"10","key":"10.1016\/j.jaad.2023.10.071_bib87","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1365-2036.2008.03843.x","article-title":"Azathioprine treatment during lactation","volume":"28","author":"Christensen","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"sup1","key":"10.1016\/j.jaad.2023.10.071_bib88","first-page":"S48","article-title":"Is it safe to continue azathioprine in breast feeding mothers?","volume":"23","author":"Khare","year":"2003","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.jaad.2023.10.071_bib89","series-title":"Rituximab [Package Insert]","year":"2010"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib90","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1399-3038.2008.00828.x","article-title":"Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin","volume":"20","author":"Palmeira","year":"2009","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaad.2023.10.071_bib91","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00415-004-0495-z","article-title":"Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis","volume":"251","author":"Achiron","year":"2004","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib92","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9378(11)90771-6","article-title":"Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication","volume":"168","author":"Ito","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib93","first-page":"241","article-title":"Sedating drugs and breastfeeding","volume":"61","author":"Chow","year":"2015","journal-title":"Can Fam Physician"},{"issue":"11","key":"10.1016\/j.jaad.2023.10.071_bib94","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00228-014-1738-2","article-title":"Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database","volume":"70","author":"Soussan","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2023.10.071_bib95","series-title":"Chlorpheniramine. Drugs and Lactation Database (LactMed) [Internet]","year":"2006"},{"key":"10.1016\/j.jaad.2023.10.071_bib96","series-title":"Diphenhydramine. Drugs and Lactation Database (LactMed) [Internet]","year":"2006"},{"key":"10.1016\/j.jaad.2023.10.071_bib97","series-title":"Hydroxyzine. Drugs and Lactation Database (LactMed) [Internet]","year":"2006"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib98","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2222.2007.02678.x","article-title":"BSACI guidelines for the management of chronic urticaria and angio-oedema","volume":"37","author":"Powell","year":"2007","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib99","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0009-9236(95)90208-2","article-title":"Terfenadine pharmacokinetics in breast milk in lactating women","volume":"57","author":"Lucas","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaad.2023.10.071_bib100","series-title":"Cetirizine. Drugs and Lactation Database (LactMed) [Internet]","year":"2006"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib101","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF03350670","article-title":"Histamine H1 receptor participation in the control of prolactin secretion in postpartum","volume":"8","author":"Messinis","year":"1985","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib102","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/jcem-52-5-924","article-title":"The effect of histamine and H1 and H2 receptors on prolactin and luteinizing hormone release in humans: sex differences and the role of stress","volume":"52","author":"Pontiroli","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"issue":"8464","key":"10.1016\/j.jaad.2023.10.071_bib103","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(85)90712-3","article-title":"Respiratory depression caused by N-desmethyldoxepin in breast milk","volume":"326","author":"Matheson","year":"1985","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib104","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2125.1985.tb05106.x","article-title":"Excretion of doxepin and N-desmethyldoxepin in human milk","volume":"20","author":"Kemp","year":"1985","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib105","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1345\/aph.18210","article-title":"Adverse effects in a newborn infant breast-fed by a mother treated with doxepin","volume":"33","author":"Frey","year":"1999","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib106","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1097\/MJT.0000000000000909","article-title":"A new safety scoring system for the use of psychotropic drugs during lactation","volume":"28","author":"Uguz","year":"2021","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.jaad.2023.10.071_bib107","series-title":"Drugs and Human Lactation","author":"Bennett","year":"1996"},{"issue":"10","key":"10.1016\/j.jaad.2023.10.071_bib108","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1016\/j.jaip.2020.05.054","article-title":"Omalizumab concentrations in pregnancy and lactation: a case study","volume":"8","author":"Saito","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaad.2023.10.071_bib109","series-title":"Safety Outcomes Among Infants Exposed to Omalizumab Via Breastfeeding: Results from the Xolair Pregnancy Registry (Expect)","first-page":"374","author":"Leon","year":"2019"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib110","doi-asserted-by":"crossref","first-page":"326","DOI":"10.18176\/jiaci.0179","article-title":"Omalizumab as third-line therapy for urticaria during pregnancy","volume":"27","author":"Ensina","year":"2017","journal-title":"J Invest Allergol Clin Immunol"},{"key":"10.1016\/j.jaad.2023.10.071_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.652973","article-title":"Case report: omalizumab for chronic spontaneous urticaria in pregnancy","volume":"12","author":"Liao","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib112","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4168\/aair.2021.13.3.515","article-title":"Safety of omalizumab during pregnancy and breast-feeding with assessment of placental transfer: a case report","volume":"13","author":"Majou","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib113","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1097\/00006534-200005000-00063","article-title":"Breast milk lidocaine levels in tumescent liposuction","volume":"105","author":"Dryden","year":"2000","journal-title":"Plast Reconstr Surg"},{"issue":"9","key":"10.1016\/j.jaad.2023.10.071_bib114","first-page":"691","article-title":"Lidocaine excretion in breast milk","volume":"20","author":"Zeisler","year":"1986","journal-title":"Drug Intell Clin Pharm"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib115","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1034\/j.1399-6576.1999.430405.x","article-title":"Excretion of lidocaine and bupivacaine in breast milk following epidural anesthesia for cesarean delivery","volume":"43","author":"Ortega","year":"1999","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib116","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijwd.2017.01.005","article-title":"A review of the safety of cosmetic procedures during pregnancy and lactation","volume":"3","author":"Trivedi","year":"2017","journal-title":"Int J Womens Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib117","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1111\/jdv.17755","article-title":"Minoxidil-Induced hypertrichosis in a breastfed infant","volume":"36","author":"Tr\u00fceb","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2023.10.071_bib118","series-title":"Diphencyprone (DCP) Treatment","year":"2021"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib119","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.det.2006.01.001","article-title":"The use of dermatologic drugs in pregnancy and lactation","volume":"24","author":"Leachman","year":"2006","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2023.10.071_bib120","series-title":"Nystatin. Drugs and Lactation Database (LactMed) [Internet]","year":"2006"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib121","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0273-2300(03)00098-9","article-title":"Exposure of babies to C15\u2013C45 mineral paraffins from human milk and breast salves","volume":"38","author":"Noti","year":"2003","journal-title":"Regul Toxicol Pharmacol"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib122","first-page":"5","article-title":"Common sense dermatological drug suggestions for women who are breast-feeding","volume":"7","author":"Zip","year":"2002","journal-title":"Skin Therapy Lett"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib123","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0190-9622(82)70109-4","article-title":"Systemic absorption of clindamycin hydrochloride after topical application","volume":"7","author":"Barza","year":"1982","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib124","first-page":"288","article-title":"Tissue and body fluid distribution of antibacterial agents in pregnant and lactating women","volume":"32","author":"Zhang","year":"1997","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib125","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/phar.2732","article-title":"Transfer of antibiotics and their metabolites in human milk: implications for infant health and microbiota","volume":"43","author":"Thomas","year":"2023","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib126","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2125.1982.tb01433.x","article-title":"Clindamycin passage into human milk","volume":"13","author":"Steen","year":"1982","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib127","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/bcp.12497","article-title":"Systemic exposure of topical erythromycin in comparison to oral administration and the effect on cytochrome P450 3A4 activity","volume":"78","author":"Carls","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2023.10.071_bib128","doi-asserted-by":"crossref","DOI":"10.1590\/s0102-865020190010000004","article-title":"Metronidazole concentration in the bloodstream following its topical application, at different concentration levels, on experimental skin wounds during healing by secondary intention","volume":"34","author":"Sampaio","year":"2019","journal-title":"Acta Cir Bras"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0196-0709(92)90023-M","article-title":"Use of antibiotics for ear, nose, and throat disorders in pregnancy and lactation","volume":"13","author":"Niebyl","year":"1992","journal-title":"Am J Otolaryngol"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib130","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0002-9378(15)30138-1","article-title":"Excretion of penicillin in human milk following parturation","volume":"51","author":"Greene","year":"1946","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib131","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1651-2227.1981.tb16553.x","article-title":"Passage of cephalosporins and amoxicillin into the breast milk","volume":"70","author":"Kafetzis","year":"1981","journal-title":"Acta Paediatr Scand"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib132","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0002-9378(94)70161-X","article-title":"Presence of azithromycin breast milk concentrations: a case report","volume":"170","author":"Kelsey","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib133","doi-asserted-by":"crossref","first-page":"812.e1","DOI":"10.1016\/j.ajog.2015.01.015","article-title":"Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis","volume":"212","author":"Sutton","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib134","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/089033449200800108","article-title":"The effect of maternal medications on breastfeeding infants","volume":"8","author":"Fleiss","year":"1992","journal-title":"J Hum Lactation"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib135","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/0002-9343(89)90021-1","article-title":"Pharmacokinetics of three newer quinolones in pregnant and lactating women","volume":"87","author":"Giamarellou","year":"1989","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib136","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/INF.0b013e3181fe353d","article-title":"Ciprofloxacin use in neonates: a systematic review of the literature","volume":"30","author":"Kaguelidou","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.jaad.2023.10.071_bib137","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1086\/430066","article-title":"Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents","volume":"40","author":"Drobac","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib138","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-3468(05)80106-X","article-title":"Perforated pseudomembranous colitis in the breast-fed infant","volume":"27","author":"Harmon","year":"1992","journal-title":"J Pediatr Surg"},{"issue":"7","key":"10.1016\/j.jaad.2023.10.071_bib139","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1055\/s-2007-1022919","article-title":"Clarithromycin, a new macrolide antibiotic. Effectiveness in puerperal infections and pharmacokinetics in breast milk","volume":"53","author":"Sedlmayr","year":"1993","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/bfm.2008.0135","article-title":"The safety of macrolides during lactation","volume":"4","author":"Goldstein","year":"2009","journal-title":"Breastfeed Med"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib141","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.66.6.1030b","article-title":"Clindamycin and breast-feeding","volume":"66","author":"Mann","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2023.10.071_bib142","first-page":"345","article-title":"Tetracycline in obstetric infections","volume":"3","author":"Konicoff","year":"1955","journal-title":"Antibiot Annu"},{"key":"10.1016\/j.jaad.2023.10.071_bib143","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0022-3476(65)80094-4","article-title":"Excretion of drugs in milk-a review","volume":"66","author":"Knowles","year":"1965","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib144","first-page":"354","article-title":"The excretion of terramycin and tetracycline in human milk","volume":"15","author":"Gruner","year":"1955","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib145","first-page":"57","article-title":"Transfer of antibiotics into maternal milk","volume":"5","author":"Matsuda","year":"1984","journal-title":"Biol Res Pregnancy Perinatol"},{"key":"10.1016\/j.jaad.2023.10.071_bib146","first-page":"669","article-title":"Pyloric stenosis associated with erythromycin ingested through breast milk","volume":"69","author":"Stang","year":"1986","journal-title":"Minn Med"},{"key":"10.1016\/j.jaad.2023.10.071_bib147","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1908","article-title":"Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study","volume":"348","author":"Lund","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib148","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/0036554021000027010","article-title":"Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides","volume":"35","author":"S\u00f8rensen","year":"2003","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib149","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/bcpt.12995","article-title":"Exposure of nursed infants to maternal treatment with ethambutol and rifampicin","volume":"123","author":"Partosch","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib150","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American thoracic society\/centers for disease control and prevention\/infectious diseases society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"10.1016\/j.jaad.2023.10.071_bib151","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1056\/NEJMra1413919","article-title":"Treatment of tuberculosis","volume":"373","author":"Horsburgh","year":"2015","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jaad.2023.10.071_bib152","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers For Disease Control and Prevention\/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib153","first-page":"539","article-title":"Using nitrofurantoin while breastfeeding a newborn","volume":"60","author":"Zao","year":"2014","journal-title":"Can Fam Physician"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib154","first-page":"24","article-title":"Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings","volume":"8","author":"Forna","year":"2006","journal-title":"AIDS Rev"},{"issue":"8","key":"10.1016\/j.jaad.2023.10.071_bib155","first-page":"475","article-title":"Acne vulgaris: diagnosis and treatment","volume":"100","author":"Og\u00e9","year":"2019","journal-title":"Am Fam Physician"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib156","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaad.2010.10.014","article-title":"Use of topical tretinoin and the development of noncutaneous adverse events: evidence from a systematic review of the literature","volume":"65","author":"Shapiro","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2023.10.071_bib157","series-title":"Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk","author":"Briggs","year":"2012"},{"issue":"8","key":"10.1016\/j.jaad.2023.10.071_bib158","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/jps.2600660841","article-title":"Spironolactone: relationship between concentrations of dethioacetylated metabolite in human serum and milk","volume":"66","author":"Phelps","year":"1977","journal-title":"J Pharmaceut Sci"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib159","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/trgh.2017.0044","article-title":"Case report: induced lactation in a transgender woman","volume":"3","author":"Reisman","year":"2018","journal-title":"Transgend Health"},{"issue":"7","key":"10.1016\/j.jaad.2023.10.071_bib160","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.ekir.2022.05.006","article-title":"Potassium and magnesium in breast milk of a woman with gitelman syndrome","volume":"7","author":"de Jong","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"7190","key":"10.1016\/j.jaad.2023.10.071_bib161","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(61)90289-6","article-title":"Suppressing lactation with oral diuretics","volume":"277","author":"Healy","year":"1961","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jaad.2023.10.071_bib162","first-page":"251","article-title":"Suppression of postpartum lactation with furosemide","volume":"50","author":"Cominos","year":"1976","journal-title":"S Afr Med J"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib163","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","article-title":"Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials","volume":"156","author":"Hebert","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib164","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jaad.2019.05.109","article-title":"Ectoparasites: scabies","volume":"82","author":"Thomas","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0625.1992.tb00185.x","article-title":"Percutaneous absorption of azelaic acid in humans","volume":"1","author":"Tauber","year":"1992","journal-title":"Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib166","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/dth.12077","article-title":"Treatment of acne vulgaris in pregnant patients","volume":"26","author":"Pugashetti","year":"2013","journal-title":"Dermatol Ther"},{"issue":"9","key":"10.1016\/j.jaad.2023.10.071_bib167","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/jdv.12061","article-title":"Adult female acne: a new paradigm","volume":"27","author":"Dr\u00e9no","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2023.10.071_bib168","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3122\/jabfm.2016.02.150165","article-title":"Treatment of\u00a0acne in pregnancy","volume":"29","author":"Chien","year":"2016","journal-title":"J Am Board Fam Med"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib169","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijwd.2019.04.021","article-title":"Clinical considerations for the management of psoriasis in women","volume":"5","author":"Gottlieb","year":"2019","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jaad.2023.10.071_bib170","series-title":"Tazarotene Gel 0.05% and Tazarotene Gel 0.1% [Package Insert]","year":"2011"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib171","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2230.1995.tb01351.x","article-title":"Benefits and risks of intralesional corticosteroid injection in the treatment of dermatological diseases","volume":"20","author":"Ffrooz","year":"1995","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib172","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/bfm.2022.0220","article-title":"Transfer of injected triamcinolone into human milk of a lactating patient suffering from idiopathic granulomatous mastitis","volume":"18","author":"Rosen-Carole","year":"2023","journal-title":"Breastfeed Med"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib173","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s13555-022-00854-3","article-title":"Treatment of acne vulgaris during pregnancy and lactation: a narrative review","volume":"13","author":"Ly","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaad.2023.10.071_bib174","series-title":"Butenafine HCl cream [Package Insert]","year":"2001"},{"key":"10.1016\/j.jaad.2023.10.071_bib175","series-title":"Clotrimazole. Drugs and Lactation Database (LactMed) [Internet]","year":"2006"},{"key":"10.1016\/j.jaad.2023.10.071_bib176","series-title":"Efinaconazole [Package Insert]","year":"2022"},{"issue":"10","key":"10.1016\/j.jaad.2023.10.071_bib177","first-page":"875","article-title":"Fluconazole use during breastfeeding","volume":"61","author":"Kaplan","year":"2015","journal-title":"Can Fam Physician"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib178","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/j.1875-9114.1988.tb04088.x","article-title":"The 4-Quinolone antibiotics: past, present, and Future","volume":"8","author":"Stein","year":"1988","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib179","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00006454-199503000-00012","article-title":"Fluconazole concentrations in breast milk","volume":"14","author":"Force","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2023.10.071_bib180","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00228-012-1468-2","article-title":"Safety of fluconazole in paediatrics: a systematic review","volume":"69","author":"Egunsola","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2023.10.071_bib181","series-title":"Most Dermatologic Drugs Safe for Breastfeeding Mothers","author":"Haelle","year":"2018"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib182","first-page":"10","article-title":"Medications in pregnancy and lactation","volume":"30","author":"McCarter-Spaulding","year":"2005","journal-title":"MCN Am J Matern Child Nurs"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib183","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/0002-9378(95)90662-2","article-title":"Disposition of maternal ketoconazole in breast milk","volume":"173","author":"Moretti","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2023.10.071_bib184","series-title":"Terbinafine. Drugs and Lactation Database (LactMed) [Internet]","year":"2006"},{"key":"10.1016\/j.jaad.2023.10.071_bib185","series-title":"Nystatin. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","year":"2020"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib186","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1523-536X.1975.tb01127.x","article-title":"Drugs in breastmilk\u2014a consumer\u2019s guide","volume":"2","author":"Rothermel","year":"1975","journal-title":"Birth"},{"issue":"1","key":"10.1016\/j.jaad.2023.10.071_bib187","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1749-6632.1993.tb26120.x","article-title":"Selenium teratogenesis species-dependent response and influence on reproduction","volume":"678","author":"Willhite","year":"1993","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib188","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-4362.1990.tb03813.x","article-title":"Suppression of lactation by selenium disulfide","volume":"29","author":"Sugathan","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2023.10.071_bib189","series-title":"Tavaborole [Package Insert]","year":"2018"},{"key":"10.1016\/j.jaad.2023.10.071_bib190","series-title":"Terbinafine [Package Insert]","year":"2010"},{"key":"10.1016\/j.jaad.2023.10.071_bib191","series-title":"Acyclovir. Drugs and Lactation Database (LactMed) [Internet]","year":"2006"},{"issue":"6","key":"10.1016\/j.jaad.2023.10.071_bib192","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0190-9622(95)91362-9","article-title":"Concentration and kinetic studies of intravenous acyclovir in serum and breast milk of a patient with eczema herpeticum","volume":"32","author":"Bork","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.10.071_bib193","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/106002809402800506","article-title":"Acyclovir excretion in human breast milk","volume":"28","author":"Taddio","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2023.10.071_bib194","series-title":"Famciclovir. Drugs and Lactation Database (LactMed) [Internet]","year":"2006"},{"key":"10.1016\/j.jaad.2023.10.071_bib195","unstructured":"American Academy of Dermatology. Pregnancy and breastfeeding. presented at: American Academy of Dermatology; 2013; Schaumburg, IL."},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib196","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ijd.1979.18.3.228","article-title":"Systemic absorption of topical salicylic acid","volume":"18","author":"Birmingham","year":"1979","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2023.10.071_bib197","series-title":"Valacyclovir. Drugs and Lactation Database (LactMed) [Internet]","year":"2006"},{"key":"10.1016\/j.jaad.2023.10.071_bib198","series-title":"Principles and Practice of Pediatric Infectious Diseases","first-page":"1324","article-title":"Ectoparasites (lice and scabies)","author":"Elston","year":"2023"},{"key":"10.1016\/j.jaad.2023.10.071_bib199","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00265962","article-title":"Ivermectin levels in\u00a0human breastmilk","volume":"45","author":"Ogbuokiri","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jaad.2023.10.071_bib200","first-page":"921","article-title":"Infestations in the pediatric patient","volume":"47","author":"Angel","year":"2000","journal-title":"Pediatr Clin"},{"issue":"3","key":"10.1016\/j.jaad.2023.10.071_bib201","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2023.10.071_bib202","series-title":"Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment","author":"Schaefer","year":"2014"},{"key":"10.1016\/j.jaad.2023.10.071_bib203","first-page":"1","article-title":"1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention","volume":"47","year":"1998","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2023.10.071_bib204","series-title":"CDC Yellow Book 2018: Health Information for International Travel","year":"2017"},{"key":"10.1016\/j.jaad.2023.10.071_bib205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.envint.2012.05.007","article-title":"Pyrethroids in human breast milk: occurrence and nursing daily intake estimation","volume":"47","author":"Corcellas","year":"2012","journal-title":"Environ Int"},{"key":"10.1016\/j.jaad.2023.10.071_bib206","series-title":"Fluorouracil [Package Insert]","year":"2021"},{"key":"10.1016\/j.jaad.2023.10.071_bib207","series-title":"Mechlorethamine [Package Insert]","year":"2020"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224001105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224001105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T01:55:16Z","timestamp":1736301316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224001105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":207,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0190962224001105"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2023.10.071","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of dermatologic medications in pregnancy and lactation: An update\u2014Part II: Lactation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.10.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.10.072","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}